Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-24 @ 2:56 PM
NCT ID:
NCT01164059
Eligibility Criteria:
Inclusion Criteria:
* Schizophrenia
* age 18-65 years
* necessity to establish new or change antipsychotic treatment due to unsatisfying results or side effects
* written informed consent
Exclusion Criteria (amongst others):
* Known or suspected hypersensitivity to olanzapine, quetiapine, aripiprazole, flupentixol or haloperidol
* Acute suicidal tendency
* "Einwilligungsvorbehalt (BGB)" or "Unterbringung (PsychKG)"
* Epilepsy
* Organic psychosis
* Parkinson Disease
* Dementia
* History of malignant neuroleptic syndrome
* QTc interval ≥ 0.5s / history of congenital QTc prolongation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01164059
Study Brief:
Protocol Section:
NCT01164059